SCINAI IMMUNOTHERAPEUTICS LTD. Financing Receivable, Credit Loss, Expense (Reversal)
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Financing Receivable, Credit Loss, Expense (Reversal) of $3.85 thousand for the 1-month period ending 2022-08-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLossesExpensed · last filed 2026-04-01
- 2022-08-31: Financing Receivable, Credit Loss, Expense (Reversal) 1 month $3.85K.
| Period end | Financing Receivable, Credit Loss, Expense (Reversal) 1 month |
|---|---|
| 2022-08-31 | $3.85K 20-F · filed 2026-04-01 |